MediGene AG.(Other News To Note)(Phase II trial of its Polyphenon E Ointment )(Brief Article)

MediGene AG, of Martinsried, Germany, said results of a Phase II trial of its Polyphenon E Ointment (15 percent) for the treatment of actinic keratosis, a precursor of skin cancer, showed that the drug demonstrated immunomodulatory properties, though …